Literature DB >> 2863640

Treatment of diarrhoea in Indonesian children: what it costs and who pays for it.

S J Lerman, D S Shepard, R A Cash.   

Abstract

The annual economic burden of diarrhoea in four subdistricts in Indonesia averaged $2.27 per child aged under 5 years when health centre, hospital, and private expenditures were all considered. The community itself spent $1.03 per child or 46% of the total; 96% of community payments went to the private sector, and 4% were for fees at government health centres and hospitals. The widespread availability of oral rehydration therapy has led to only partial abandonment of ineffective or marginally effective medications; non-rehydration medications amounted to 44% of total treatment expenditures. Most medication costs were for antimicrobial agents, such as tetracycline in the government sector and iodochlorhydroxyquin in the private sector. If the use of tetracycline at health centres could be restricted to 10% of episodes treated instead of the present 88%, their costs could be reduced by 50%.

Entities:  

Keywords:  Antibiotics; Asia; Biology; Commerce; Developing Countries; Development Planning; Diarrhea; Diarrhea, Infantile; Diseases; Drugs; Economic Factors; Equipment And Supplies--cost; Evaluation; Gastrointestinal Effects; Government Sponsored Programs; Incidence; Indonesia; Macroeconomic Factors; Measurement; Oral Rehydration; Organization And Administration; Physiology; Private Sector; Programs; Southeastern Asia; Treatment--cost

Mesh:

Substances:

Year:  1985        PMID: 2863640     DOI: 10.1016/s0140-6736(85)90013-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Drug utilisation patterns in the Third World.

Authors:  J S Bapna; C D Tripathi; U Tekur
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

2.  Antidiarrhoeal drugs for acute diarrhoea in children.

Authors:  A M Costello; T I Bhutta
Journal:  BMJ       Date:  1992-01-04

3.  Modeling risk categories to predict the longitudinal prevalence of childhood diarrhea in Indonesia.

Authors:  Laura C Sima; Reuben Ng; Menachem Elimelech
Journal:  Am J Trop Med Hyg       Date:  2013-09-09       Impact factor: 2.345

Review 4.  Ridding the world of hydroxyquinolines.

Authors:  M E Claeson; M L Clements
Journal:  BMJ       Date:  1989-08-26

Review 5.  Pharmacoeconomics of the therapy of diarrhoeal disease.

Authors:  K A Nathavitharana; I W Booth
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

6.  Costs of diarrhoeal diseases and the savings from a control programme in Cebu, Philippines.

Authors:  B C Forsberg; E Sullesta; S Pieche; N Lambo
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

7.  Costs of illness due to endemic cholera.

Authors:  C Poulos; A Riewpaiboon; J F Stewart; J Clemens; S Guh; M Agtini; D Sur; Z Islam; M Lucas; D Whittington
Journal:  Epidemiol Infect       Date:  2011-04-18       Impact factor: 2.451

8.  Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.

Authors:  J Murray; D A McFarland; R J Waldman
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

9.  Relationship between use of water from community-scale water treatment refill kiosks and childhood diarrhea in Jakarta.

Authors:  Laura C Sima; Mayur M Desai; Kathleen M McCarty; Menachem Elimelech
Journal:  Am J Trop Med Hyg       Date:  2012-11-05       Impact factor: 2.345

10.  Economic evaluation of zinc and copper use in treating acute diarrhea in children: A randomized controlled trial.

Authors:  Archana B Patel; Leena A Dhande; Manwar S Rawat
Journal:  Cost Eff Resour Alloc       Date:  2003-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.